Try our mobile app
US Leaders — Screener 
Technology
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Apple 261.73 -5.0% 0.4% 1.1% 
15.7% 
17.8%
16.7% 
5.2%
 27.3x
Google 309.37 -0.6% 0.3% -0.1% 
15.9% 
13.3%
14.6% 
13.7%
 27.5x
Microsoft 401.84 -0.6% 0.9% 1.1% 
16.7% 
23.4%
20.0% 
19.3%
 16.1x
Amazon 199.60 -2.2% 0.0% 0.3% 
13.4% 
10.9%
12.2% 
25.9%
 14.9x
Facebook 649.81 -2.8% 0.3% 0.0% 
23.8% 
8.4%
16.1% 
32.9%
 17.3x
Broadcom 331.17 -3.4% 0.7% 1.3% 
28.2% 
104.0%
66.1% 
26.6%
 56.5x
Netflix 75.86 -4.7% 0.0% 2.6% 
17.2% 
11.6%
14.4% 
23.8%
 25.3x
Texas Instruments 223.00 -1.6% 2.5% -0.8% 
10.4% 
12.0%
11.2% 
-6.0%
 26.6x
Salesforce 185.43 +0.2% 0.9% 0.8% 
8.6% 
11.0%
9.8% 
24.5%
 13.3x
Adobe 262.50 +2.1% 0.0% 1.0% 
10.7% 
8.0%
9.4% 
12.2%
 13.0x
Payments
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Visa 324.18 -1.5% 0.8% --- 
11.5% 
-4.3%
3.6% 
6.5%
 30.5x
Mastercard 527.46 -1.9% 0.6% --- 
17.6% 
21.5%
19.5% 
9.6%
 34.3x
Hardware
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Nvidia 186.94 -1.6% 0.0% 0.9% 
62.5% 
64.5%
63.5% 
100.3%
 40.5x
QUALCOMM 138.47 -1.8% 2.6% 0.0% 
5.0% 
-5.8%
-0.4% 
2.2%
 11.6x
Communications
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Cisco 75.00 -12.3% 2.2% 1.4% 
7.5% 
26.1%
16.8% 
2.8%
 20.5x
AT&T 28.80 +1.2% 3.8% -0.6% 
3.6% 
2.0%
2.8% 
13.4%
 8.0x
Verizon 49.46 +1.0% 5.6% 3.2% 
1.5% 
22.5%
12.0% 
4.2%
 7.4x
Comcast 31.82 -2.0% 4.0% 3.6% 
-2.7% 
-1.9%
-2.3% 
9.4%
 6.1x
Entertainment
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Disney 102.38 -5.3% 1.5% 0.1% 
5.2% 
-3.0%
1.1% 
26.1%
 12.3x
Consumer Brand
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Procter & Gamble 161.21 +0.8% 2.6% -0.3% 
1.5% 
-4.3%
-1.4% 
5.3%
 18.5x
Coca-Cola 79.00 +0.5% 2.6% -0.1% 
2.4% 
-30.4%
-14.0% 
7.0%
 25.3x
Philip Morris 188.95 +1.4% 3.0% -0.4% 
9.4% 
14.8%
12.1% 
8.6%
 20.5x
PepsiCo 167.20 -1.2% 3.4% -1.5% 
5.6% 
42.6%
24.1% 
6.0%
 17.5x
Nike 61.10 -2.0% 2.6% -1.4% 
0.6% 
-27.8%
-13.6% 
-13.3%
 115.9x
Food
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
McDonalds 332.08 +2.7% 2.2% -0.5% 
3.0% 
0.2%
1.6% 
6.7%
 21.4x
Retail
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Walmart 133.64 +3.8% 0.7% -0.6% 
5.8% 
3.4%
4.6% 
9.0%
 26.8x
Costco Wholesale 998.86 +2.1% 0.5% 1.1% 
15.0% 
12.8%
13.9% 
9.3%
 34.3x
Home Depot 390.22 -0.1% 2.4% 2.9% 
2.8% 
0.0%
1.4% 
-0.3%
 18.4x
Pharma
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Eli Lilly 1 038.27 +2.3% 0.6% -0.5% 
53.9% 
200.0%
126.9% 
44.0%
 38.9x
Johnson & Johnson 244.55 +1.5% 2.1% -1.5% 
6.8% 
78.8%
42.8% 
16.4%
 17.3x
AbbVie 227.50 +3.0% 2.9% 0.2% 
9.1% 
-47.9%
-19.4% 
-9.8%
 47.6x
Merck 119.24 -0.1% 2.8% 0.1% 
3.7% 
49.7%
26.7% 
9.1%
 12.3x
United Health 284.37 +2.0% 3.1% -3.3% 
12.2% 
-44.5%
-16.1% 
6.6%
 10.7x
Thermo Fisher Scientific 509.82 -3.3% 0.3% -20.3% 
4.9% 
5.5%
5.2% 
-3.2%
 23.4x
Abbott 111.47 -1.9% 2.1% 0.9% 
6.9% 
10.9%
8.9% 
-1.5%
 22.1x
Danaher 214.94 -2.3% 0.6% 0.9% 
4.6% 
4.8%
4.7% 
-4.9%
 31.5x
Pfizer 27.47 -0.9% 6.2% 7.1% 
-5.9% 
-22.8%
-14.4% 
0.8%
 12.7x
Bristol-Myers Squibb 59.86 -0.1% 4.2% 6.8% 
2.8% 
85.8%
44.3% 
-0.9%
 19.9x
Equipment
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Tesla 417.07 -2.6% 0.0% 0.6% 
11.6% 
-20.1%
-4.3% 
-0.4%
 121.5x
Raytheon Technologies 201.14 +2.4% 1.3% 1.8% 
12.1% 
15.5%
13.8% 
14.4%
 24.0x
Market Attractiveness Index

Market Attractiveness Index

calculated as average express-upside for TOP-5 US companies with highest potential

High values of index (>30%), indicate favorable moments for additional cash contributions to the stock market / stock purchases

Current value of the Index is 75.4%

chart technology by TradingView

Portfolios

Invest in a rotating portfolio of top US-based, non-financial companies. Strategy results are shown below. This page contains financial information on the 40 companies we screen for our portfolio. For a detailed overview of our US Leaders strategy and rationale behind it, follow the link

US Leaders
since 2019-08-25

-2.0%

-1.4%
day

-0.3%

0.7%
week

+312.3%

140.6%
Since inception

0.0%

SP500
Since inception
KNOW MORE →

Target portfolio structure
Company Price Day change Week change target share Value Creation Web 3m traffic
59.86  -0.1%  +0.6% 34.6% 51.2%
119.24  -0.1%  -0.4% 26.4% 32.7%
75.00  -12.3%  -8.9% 14.3% 17.7%
401.84  -0.6%  +2.1% 13.2% 16.3%
167.20  -1.2%  -0.2% 11.5% 24.9%
Actual Performance
Period Strategy SP&500
 
2019 +9.9% +13.5%
2020 +14.2% +16.2%
2021 +30.6% +27.4%
2022 -17.1% -19.7%
2023 +58.3% +24.2%
2024 +37.6% +23.5%
2025 +29.6% +16.4%
2026 +7.3% -0.1%
 
Annualized +24.4% +14.5%
 
Day -2.0% -1.4%
Week -0.3% +0.7%
Year to date +7.3% -0.1%
Since inception (2019-08-25) +312.3% +140.6%
Maximum drawdown
28.5%
Date of drawdown
2022-09-30
Sharpe ratio
1.14
Volatility (year)
18%
Portfolio (USD) and S&P500 dynamics (%)
chart technology by TradingView

Reviews

2026-02-11
#reports #KO

Coca-Cola (Soft drinks poducer) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=KO&q=2025 q4&id=915065)
(2026-02-10, Before Market Open):

- Revenue +2.4% YoY (vs +5.1% in previous quarter and historical rate +3.7%)
- EBITDA -30.4% YoY (vs +53.0% in previous quarter and historical rate +10.2%)
- EBITDA margin 17.6% decreased compared to 25.9% same period last year
- Net Debt decreased by $1.9 bln since the start of the year (0.6% of market cap)
- FCF (LTM) -$2.2 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 24.6x compared to historical level (75th percentile) of 27.9x
expected multiple is 20.5x
2026-02-11
#reports #GILD

Gilead Sciences (Medicines manufacturer) reported for 2025 q4
(2026-02-10, After Market Close):

- Revenue +4.7% YoY (vs +3.0% in previous quarter and historical rate +1.1%)
- EBITDA -15.6% YoY (vs +96800.0% in previous quarter and historical rate +5.5%)
- EBITDA margin 31.8% decreased compared to 39.5% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (0.7% of market cap)
- FCF (LTM) +$0.6 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 62.5x
2026-02-11
#reports #DD

DuPont (Chemical materials producer ) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=DD&q=2025 q4&id=915050)
(2026-02-10, Before Market Open):

- Revenue -45.2% YoY (vs -3.8% in previous quarter and historical rate -8.4%)
- EBITDA -68.4% YoY (vs -26.1% in previous quarter and historical rate -17.0%)
- EBITDA margin 6.4% decreased compared to 11.1% same period last year
- Net Debt decreased by $4 bln since the start of the year (16.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.0% of market cap
- EV/EBITDA multiple is 21.2x compared to historical level (75th percentile) of 25.4x
2026-02-11
#reports #CVS

CVS health (Prescription drug provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194812)
(2026-02-11, Before Market Open):

- Revenue +19.5% YoY (vs +4.2% in previous quarter and historical rate +21.0%)
- EBITDA +160.1% YoY (vs -20.7% in previous quarter and historical rate -13.7%)
- EBITDA margin 2.8% increased compared to 1.3% same period last year
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 18.7x
2026-02-10
#reports #VZ

Verizon (Telecommunications company) reported for 2025 q4
(2026-01-30, Before Market Open):

- Revenue +287.3% YoY (vs +1.5% in previous quarter and historical rate +16.8%)
- EBITDA +300.1% YoY (vs +22.5% in previous quarter and historical rate +24.8%)
- EBITDA margin 34.5% increased compared to 33.4% same period last year
- Net Debt increased by $17.5 bln since the start of the year (9.0% of market cap)
- FCF (LTM) -$11.9 bln (negative), 6.1% of market cap
- EV/EBITDA multiple is 4.4x compared to historical level (75th percentile) of 8.4x
expected multiple is 6.7x

At the opening of the session the share price went up +5.5%

Growth potential increased by 199.2% to +245.1%
2026-02-10
#reports #UNH

United health (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=UNH&q=2025 q4&id=909407)
(2026-01-27, Before Market Open):

- Revenue +344% YoY (vs +12.2% in previous quarter and historical rate +27.0%)
- EBITDA +161.6% YoY (vs -44.5% in previous quarter and historical rate +13.1%)
- EBITDA margin 5.2% decreased compared to 8.7% same period last year
- Net Debt decreased by $9.3 bln since the start of the year (3.6% of market cap)
- FCF (LTM) +$8.2 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 6.9x compared to historical level (75th percentile) of 15.3x
expected multiple is 13.1x

At the opening of the session the share price went down -16.0%

According to our model the company`s growth potential is 187.6%
2026-02-10
#reports #TSLA

Tesla (Vehicles manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=132682)
(2026-01-28, Before Market Open):

- Revenue +268.9% YoY (vs +11.6% in previous quarter and historical rate +23.2%)
- EBITDA +282.1% YoY (vs -20.1% in previous quarter and historical rate +2.8%)
- EBITDA margin 12.4% increased compared to 12.0% same period last year
- Net Debt increased by $25.1 bln since the start of the year (1.9% of market cap)
- FCF (LTM) -$19.4 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 68.9x compared to historical level (75th percentile) of 87.1x
expected multiple is 133.2x

At the opening of the session the share price went up +1.5%

According to our model the company`s growth potential is negative
2026-02-10
#reports #TMO

Thermo Fisher Scientific (Medical equipment manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=TMO&q=2025 q4&id=911056)
(2026-01-29, Before Market Open):

- Revenue +291% YoY (vs +4.9% in previous quarter and historical rate +15.9%)
- EBITDA +372.4% YoY (vs +5.5% in previous quarter and historical rate +13.3%)
- EBITDA margin 24.4% increased compared to 20.2% same period last year
- Net Debt decreased by $4.2 bln since the start of the year (1.9% of market cap)
- FCF (LTM) -$33.7 bln (negative), 15.8% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 26.2x
expected multiple is 26x

At the opening of the session the share price went down -3.7%

Growth potential increased by 151.0% to +151.9%
2026-02-10
#reports #PM

Philip Morris (Producer of cigarettes and tobacco products) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=PM&q=2025 q4&id=914373)
(2026-02-06, Before Market Open):

- Revenue +318.3% YoY (vs +9.4% in previous quarter and historical rate +24.7%)
- EBITDA +357.2% YoY (vs +14.8% in previous quarter and historical rate +26.1%)
- EBITDA margin 42.1% increased compared to 38.5% same period last year
- Net Debt decreased by $4 bln since the start of the year (1.4% of market cap)
- FCF (LTM) -$0.6 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 10.9x compared to historical level (75th percentile) of 18.2x
expected multiple is 19.2x

At the opening of the session the share price went down -1.2%

Growth potential increased by 123.9% to +118.3%
2026-02-10
#reports #PFE

Pfizer (The largest farm company) reported for 2025 q4
(2026-02-03, Before Market Open):

- Revenue +252.3% YoY (vs -5.9% in previous quarter and historical rate +6.2%)
- EBITDA +747.7% YoY (vs -22.8% in previous quarter and historical rate +25.9%)
- EBITDA margin 24.1% increased compared to 10.0% same period last year
- Net Debt decreased by $47 bln since the start of the year (31.0% of market cap)
- FCF (LTM) +$44.2 bln (positive), 29.1% of market cap
- EV/EBITDA multiple is 6.9x compared to historical level (75th percentile) of 19.3x
expected multiple is 13.1x

At the opening of the session the share price went down -4.9%

According to our model the company`s growth potential is 427.2%
2026-02-10
#reports #NKE

Nike (Sportswear and footwear manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=NKE&q=2025 q4&id=904845)
(2025-12-18, After Market Close):

- Revenue +0.6% YoY (vs +1.1% in previous quarter and historical rate -3.3%)
- EBITDA -27.8% YoY (vs -23.3% in previous quarter and historical rate -23.4%)
- EBITDA margin 8.0% decreased compared to 11.2% same period last year
- Net Debt increased by $1.8 bln since the start of the year (1.9% of market cap)
- FCF (LTM) -$1.4 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 118.7x compared to historical level (75th percentile) of 33.3x
expected multiple is 129.7x

At the opening of the session the share price went down -12.6%
2026-02-10
#reports #NFLX

Netflix (The largest streaming service) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=131672)
(2026-01-20, After Market Close):

- Revenue +340.9% YoY (vs +17.2% in previous quarter and historical rate +27.9%)
- EBITDA +1184.4% YoY (vs +11.6% in previous quarter and historical rate +53.6%)
- EBITDA margin 66.9% increased compared to 23.0% same period last year
- Net Debt increased by $0.3 bln since the start of the year (0.1% of market cap)
- FCF (LTM) +$16.7 bln (positive), 4.8% of market cap
- EV/EBITDA multiple is 8.9x compared to historical level (75th percentile) of 39.2x
expected multiple is 26.1x

At the opening of the session the share price went down -5.4%

According to our model the company`s growth potential is 394.3%
2026-02-10
#reports #MRK

Merck (Medical products and equipment manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=133028)
(2026-02-03, Before Market Open):

- Revenue +316.1% YoY (vs +3.7% in previous quarter and historical rate +19.5%)
- EBITDA +372.5% YoY (vs +49.7% in previous quarter and historical rate +31.7%)
- EBITDA margin 39.0% increased compared to 34.4% same period last year
- Net Debt decreased by $23.2 bln since the start of the year (7.8% of market cap)
- FCF (LTM) +$23.5 bln (positive), 7.9% of market cap
- EV/EBITDA multiple is 6.9x compared to historical level (75th percentile) of 30.7x
expected multiple is 10.7x

At the opening of the session the share price went down -1.5%

Growth potential increased by 286.3% to +483.8%
2026-02-10
#reports #GOOG

Google (Web search and mobile software provider) reported for 2025 q4
(2026-02-04, After Market Close):

- Revenue +317.7% YoY (vs +15.9% in previous quarter and historical rate +27.7%)
- EBITDA +411.6% YoY (vs +13.3% in previous quarter and historical rate +34.3%)
- EBITDA margin 44.7% increased compared to 36.5% same period last year
- Net Debt increased by $106.1 bln since the start of the year (2.5% of market cap)
- FCF (LTM) -$68.7 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 14.5x compared to historical level (75th percentile) of 20.6x
expected multiple is 27.7x

At the opening of the session the share price went down -6.0%

Growth potential increased by 100.0% to +74.9%
2026-02-10
#reports #CMCSA

Comcast (Telecommunications company) reported for 2025 q4
(2026-01-29, Before Market Open):

- Revenue +287.6% YoY (vs -2.7% in previous quarter and historical rate +17.2%)
- EBITDA +425.5% YoY (vs -1.9% in previous quarter and historical rate +35.2%)
- EBITDA margin 37.5% increased compared to 27.7% same period last year
- Net Debt increased by $10.7 bln since the start of the year (7.5% of market cap)
- FCF (LTM) +$0.9 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 3.2x compared to historical level (75th percentile) of 8.6x
expected multiple is 6.1x

At the opening of the session the share price went down -2.7%

According to our model the company`s growth potential is 395.0%
2026-02-10
#reports #AMZN

Amazon (E-commerce giant) reported for 2025 q4
(2026-02-05, After Market Close):

- Revenue +281.8% YoY (vs +13.4% in previous quarter and historical rate +27.2%)
- EBITDA +289.8% YoY (vs +10.9% in previous quarter and historical rate +55.5%)
- EBITDA margin 20.0% increased compared to 19.6% same period last year
- Net Debt increased by $25 bln since the start of the year (1.2% of market cap)
- FCF (LTM) -$36.5 bln (negative), 1.7% of market cap
- EV/EBITDA multiple is 8.9x compared to historical level (75th percentile) of 21.7x
expected multiple is 14.9x

At the opening of the session the share price went down -9.0%

According to our model the company`s growth potential is 189.9%
2026-02-10
#reports #ADBE

Adobe ( Software products and technologies developer) reported for 2025 q4
(2025-12-10, After Market Close):

- Revenue +324% YoY (vs +10.7% in previous quarter and historical rate +26.3%)
- EBITDA +348.2% YoY (vs +8.0% in previous quarter and historical rate +30.5%)
- EBITDA margin 41.0% increased compared to 38.8% same period last year
- Net Debt increased by $0.5 bln since the start of the year (0.4% of market cap)
- FCF (LTM) +$11.5 bln (positive), 9.5% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 33.7x
expected multiple is 12.8x

At the opening of the session the share price went down -0.4%

According to our model the company`s growth potential is 404.1%
2026-02-08
(review)
Weekly results
for USD strategies

US Leaders: +7.6%

Global Commodities: +3.2%

Trending Ideas: -1.2%

Rising Stars: -1.6%

vs S&P500: -0.1%
2026-02-08
#dividend #AOMR

Angel Oak Mortgage, Inc. will pay dividends in the amount of 0.32 USD per share on 2026-02-19, which is 3.6% of the current price 8.99. Together with previous payments, the annual dividend yield will be 14.2%

(2025-11-17: 0.32 USD)
(2025-08-21: 0.32 USD)
(2025-05-21: 0.32 USD)
2026-02-08
#dividend #KRT

Karat Packaging Inc. will pay dividends in the amount of 0.45 USD per share on 2026-02-19, which is 1.8% of the current price 24.39. Together with previous payments, the annual dividend yield will be 7.4%

(2025-11-20: 0.45 USD)
(2025-08-19: 0.45 USD)
(2025-05-15: 0.45 USD)
2026-02-07
#dividend #PEP

PepsiCo will pay dividends in the amount of 1.423 USD per share on 2026-03-05, which is 0.8% of the current price 170.49. Together with previous payments, the annual dividend yield will be 3.3%

(2025-12-04: 1.423 USD)
(2025-09-04: 1.423 USD)
(2025-06-05: 1.423 USD)